LZI Buprenorphine II Enzyme Immunoassay
K-Number: K253082 · 2026-01-16
Device Summary
Frequently Asked Questions
What is the LZI Buprenorphine II Enzyme Immunoassay?
LZI Buprenorphine II Enzyme Immunoassay is a medical device that received FDA 510(k) clearance on 2026-01-16. The listed applicant is Lin-Zhi International, Inc.. The 510(k) number is K253082.
When did LZI Buprenorphine II Enzyme Immunoassay receive FDA 510(k) clearance?
LZI Buprenorphine II Enzyme Immunoassay received FDA 510(k) clearance on 2026-01-16, under 510(k) number K253082.
Who is the listed applicant for LZI Buprenorphine II Enzyme Immunoassay?
The FDA 510(k) record lists Lin-Zhi International, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for LZI Buprenorphine II Enzyme Immunoassay?
The FDA product code for LZI Buprenorphine II Enzyme Immunoassay is DJG.
Other records listing Lin-Zhi International, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: DJG)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.